Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Acura Pharmaceuticals, Inc. (ACUR)

-NasdaqCM
1.30 Up 0.02(1.17%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaACURA PHARMACEUTICALS INC (ACUR) - REPORT FOR ACTIVE TRADERS1$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-generic Drugs17$49
Apr 16, 2014New Constructs, LLCN/AACUR: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014S&P Capital IQ Quantitative ReportN/AAcura Pharmaceuticals10$115
Apr 11, 2014Pechala's ReportsFrantisek PechalaACURA PHARMACEUTICALS INC (ACUR) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP , TGTX -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: ACURA PHARMACEUT -- ACUR1$11.50
Apr 4, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Acura Pharmaceuticals, Inc.41$75
Apr 3, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACURA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20

View All Reports for ACUR ...